After KE Sdn. Bhd. (KE) and Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced a merger agreement, the stock of the former saw a notable spike on
The South San Francisco-based development stage company, Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) skyrocketed over 2300% to trade at $4.0200 in pre-market session soon after the company
Share of Titan Pharmaceuticals (NASDAQ: TTNP) traded down -20.46% during the trading session of Monday after the company disclosed that it has settled all of
Titan Pharmaceuticals (NASDAQ: TTNP) shares soared 28.71% during the pre-market trading session of Tuesday after the company announced that it has signed an Asset Purchase
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.